BIOTYPE GmbH

BIOTYPE develops, manufactures and distributes molecular diagnostic kits for the detection and quantification of RNA and DNA markers. The assays support diagnosis and therapy in oncology, hemato-oncology, dermatology and forensics. BIOTYPE also provides custom development & manufacturing of molecular diagnostic kits. We design and realize molecular assays on various platforms ranging from a prototype via RUO to CE-IVD. The company's goal is to provide customers, such as laboratories, pharmaceutical, and diagnostic companies, with safe and robust molecular genetic tools.  

All our tests are PCR-based and run either on commercial qPCR devices or on our Modaplex device. The Modaplex system provides a novel real-time quantification procedure through the unique combination of PCR and simultaneous capillary electrophoresis. This technology enables the examination of up to 2,000 DNA/RNA targets in one run. With little hands-on time and a simple workflow it allows to detect all types of genetic aberrations.  

Company profile

• Foundation - 1999
• Management - Dr. Norman Gerstner, Dr. Felix Zörgiebel
• Location - Dresden, Germany, GebäudeEnsemble Deutsche Werkstätten Hellerau
• Activities - Applied research and development, production, and distribution
• Facilities – 1000 m² composed of high-tech molecular biology labs with DNA, biochemistry and microbiology departments, as well as cleanrooms and office space